Hyderabad: BioAsia, the annual flagship event of the Government of Telangana has over the years emerged as a preeminent technology and bio-business convention in Asia for Life sciences, pharmaceuticals and healthcare. Organized by the Department of Industries and Commerce, Government of Telangana, the 14th Edition of BioAsia is expected to bring together eminent industry leaders from across the globe. Demonstrating its dominant position, the event scheduled for February 6-8, 2017 is all set to bring together some of the most influential global corporate leaders to Hyderabad which is being termed as the life sciences hub of India.
The 14th edition of the event, which is all set to be the biggest gathering, will have the likes Dr Paul Stoffels, Worldwide Chairman of Pharmaceuticals and Chief Scientific Officer, Johnson & Johnson, Mr Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Novartis, Dr. Patrick Vallance, President Worldwide Pharmaceuticals, R&D – GSK, among many others. With combined revenues, of the 3 companies, of about USD 170 Billion (*), Johnson and Johnson and Novartis are listed as top two pharmaceutical companies in the world. While Dr Paul Stoffels is recognized globally as the champion of innovation and drug development as he led the development of a number of leading products for the treatment of HIV, Mr. Vasant Narasimhan has been listed in the prestigious Fortune’s ’40 Under 40′ 2015. Dr Patrick Vallance is the person driving GSK’s efforts to combat antibiotic resistance, said the press release from organizers.
BioAsia 2017 is expected to have participation of 1,500 delegates from 50 countries with 100 High profile speakers and 800 Corporates.
Mr Narayana Murthy, Founder, Infosys, Prof Kurt Wuthrich, Nobel Laureate in Chemistry, Scripps Research Institute, USA, Dr Satish Reddy, Chairman, Dr Reddy’s Laboratories, Dr Shailesh Ayyangar, Managing Director – Sanofi India and VP South Asia, Sanofi, Mr BVR Mohan Reddy, Founder & Executive Chairman, CYIENT and Former Chairman, NASSCOM, Ms. Zenia Tata, Executive Director, Global Development & International Expansion, XPRIZE USA, Dr Murtaza Khorakiwala, Managing Director of Wockardt, Mr S Sridhar, Managing Director of Pfizer India, Mr Sanjiv Navangul, Managing Director of Janssen India, Mr K G Ananthakrishnan, Managing Director of MSD India, Mr Srini Srinivasan, Managing Director of Hospira India, among many others will participate in the event.
The statement from BioAsia organizers also stated that the Department of Industries and Commerce, Government of Telangana under the leadership of Mr K T Ramarao, Minister for Industries and Commerce, IT, E&C, MAUD and NRI Affairs, is making every effort to make this event a historic one and a help add momentum to some its landmark initiatives in the sector including Hyderabad Pharma City, Genome Valley and Medical Devices Park. Deloitte will be the Knowledge Partner for the event.
While announcing the speakers for the event, Mr Shakthi Nagappan, CEO, BioAsia said, “In its journey of 14 years, the flagship event of Telangana – BioAsia has emerged as the largest Life Science event in India and one of the pre-eminent meetings in Asia. With continued commitment of the State Government to Life Sciences sector, BioAsia 2017 is expected to be bigger and will witness participation of life sciences and healthcare leaders from over 50 Countries”.
BioAsia2016 witnessed participation of around 1300 registered delegates from 50 countries. It also conducted around 1200 trade, partnership and deliberation meetings at the event. The 2017 edition will also have a Buyer Seller Meet wherein a large number of international buyers will participate.